Title for MeetingAbstracts
Alphabetical listing of titles
V beta 8 specific anergy in T cells from asymptomatic HIV-infected individuals is not associated with an abnormal representation of the V beta 8 T cell subset.
V delta 1 repertoire of gamma delta T cells in human peripheral lymphocytes. influence of HIV-infection.
V delta repertoire of gamma delta-T cells in peripheral lymphocytes during HIV-infection: cellular and molecular characterization of delta TCS1+ T cells.
V-beta T cell repertoire is restored by HAART in patients with primary, acute HIV infection but not in treatment-naive HIV+ patients with chronic infection.
V-Glycopeptide: Phase1 Single and Multiple-dose Placebo Controlled Intravenous Safety, Pharmacokinetic, and Pharmacodynamic Study in Healthy Subjects.
V1/V2 amino acid sequence analysis of HIV-1 Subtype C from children with rapid and slow disease progression.
V106M AND V179D, A NOVEL HIV-1 REVERSE TRANSCRIPTASE (RT) COMBINATION OF MUTATIONS CONFERRING HIGH-LEVEL RESISTANCE TO NON-NUCLEOSIDE RT INHIBITORS.
V2 extension of HIV-1 is associated with slow/moderate disease progression.
V3 Antibodies and Heteroduplex Mobility Assay results in HIV-1 Infected Individuals from Venezuela.
V3 epitope-grafted immunoglobulin as a new AIDS vaccine candidate.
V3 epitopes can mediate antibody neutralization and enhancement of HIV-1 infection.
V3 loop binding protein from cellular membrane fractions of Molt-4 cells.
V3 loop binding protein from U937 cells.
V3 loop diversity in the cohort of patients with multiple transmissions of HIV-1 presumably originating from the same source.
V3 loop immunoreactivity and diversity among HIV-1 isolates from the Philippines.
V3 loop peptide antibodies in Haitian women and infant HIV-1 infections.
V3 loop sequences and HIV-1 perinatal transmission.
V3 loop structure and electrostatics: influence on HIV infectivity and pathogenesis.
V3 multi-epitope polypeptides. The number of V3 regions affects the exposition of epitopes and the immunogenicity.
V3 octapeptide motif of HIV-1 strains derived from six different regions of the brain of a patient with AIDS-related dementia exhibit high degree of variability.
V3 of HIV-1 subtype C is over-represented in intersubtype A, C and D recombinant genotypes from perinatally infected infants in Tanzania.
V3 peptides corresponding to T-tropic HIV-1 can directly bind to CXCR4 and inhibit T-tropic HIV-1 infection.
V3 region sequences from HIV-1 isolates from India.
V3 sequence diversity among Brazilian HIV-1 samples.
V3 sequence diversity of HIV-1 subtype E in infected mothers and their infants.
V3 sequence variants and viral selection in cultured HIV Mexican isolates.
V3 serotyping of HIV-1 infection in the Philippines.
V3 serotyping of HIV-1 infection: correlation with genotyping, limitations and identification of subtype-specific amino-acid sequences.
V3 variability of HIV-1 isolates from Ethiopia.
V3-based PEIA for serodifferentiation of HIV types and subtypes: non-B HIV-1 subtypes contribute to the epidemic in Germany, Spain and Israel.